Diabetes Care, Vol 15, Issue 9 1141-1155, Copyright © 1992 by American Diabetes Association

ARTICLES

Diabetes mellitus and macrovascular complications. An epidemiological perspective

RP Donahue and TJ Orchard
University of Miami School of Medicine, Department of Epidemiology and Public Health, Florida 33136.

It is clearly recognized that patients with NIDDM have an increased risk for CHD. Recent data indicate that persons with glucose concentrations in the nondiabetic range also may be at higher risk for CHD. These associations may not represent cause and effect, however. Emerging data suggest that hyperglycemia and CHD may both arise from hyperinsulinemia/insulin resistance. In support of this hypothesis are studies showing that NIDDM and CHD have many risk factors in common, including age, elevated blood pressure, dyslipidemia, adiposity, and a central pattern of fat distribution. Moreover, these risk factors are frequent concomitants of hyperinsulinemia, itself a risk factor for CHD and perhaps for NIDDM. Although the duration of NIDDM has been infrequently related to risk of CHD, the authors hypothesize that duration of hyperinsulinemia/insulin resistance would be a more sensitive marker for risk of CHD. The relation of IDDM to CHD is a different situation. The etiological process leading to IDDM, namely the destruction of beta-cells in genetically predisposed persons, is not related to cardiovascular risk. However, IDDM patients still have an excess of CVD, the risk factors for which may vary according to the location of the diseases (e.g., LEAD vs. CHD). There is a strong relationship between proteinuria and CVD, which has led to a general theory of vascular complications in IDDM based on defective heparan sulfate metabolism (Steno hypothesis). Recent evidence challenges parts of this hypothesis, and the possibility is raised that a higher case-fatality rate in a subgroup of patients with both renal and CVD explains part of the renal connection, as does the general worsening of CVD risk factors.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. P. Donahue, S. Stranges, K. Rejman, L. B. Rafalson, J. Dmochowski, and M. Trevisan Elevated Cystatin C Concentration and Progression to Pre-Diabetes: The Western New York Study Diabetes Care, July 1, 2007; 30(7): 1724 - 1729. [Abstract] [Full Text] [PDF]

				R. Dalla Pozza, S. Bechtold, W. Bonfig, S. Putzker, R. Kozlik-Feldmann, H. Netz, and H.-P. Schwarz Age of Onset of Type 1 Diabetes in Children and Carotid Intima Medial Thickness J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2053 - 2057. [Abstract] [Full Text] [PDF]

				R. P. Donahue, K. Rejman, L. B. Rafalson, J. Dmochowski, S. Stranges, and M. Trevisan Sex Differences in Endothelial Function Markers Before Conversion to Pre-Diabetes: Does the Clock Start Ticking Earlier Among Women?: The Western New York Study Diabetes Care, February 1, 2007; 30(2): 354 - 359. [Abstract] [Full Text] [PDF]

				R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF]

				S. P. Marso and W. R. Hiatt Peripheral Arterial Disease in Patients With Diabetes J. Am. Coll. Cardiol., March 7, 2006; 47(5): 921 - 929. [Abstract] [Full Text] [PDF]

				B. E.K. Klein, R. Klein, P. E. McBride, S. E. Moss, R. J. Prineas, and J. O. Reinke Electrocardiographic Abnormalities in Individuals With Long-Duration Type 1 Diabetes Diabetes Care, January 1, 2005; 28(1): 145 - 147. [Full Text] [PDF]

				Asia Pacific Cohort Studies Collaboration Blood Glucose and Risk of Cardiovascular Disease in the Asia Pacific Region Diabetes Care, December 1, 2004; 27(12): 2836 - 2842. [Abstract] [Full Text] [PDF]

				E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. L. Brancati, N. R. Powe, and S. H. Golden Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus Ann Intern Med, September 21, 2004; 141(6): 421 - 431. [Abstract] [Full Text] [PDF]

				S. Nomura, A. Shouzu, S. Omoto, M. Nishikawa, T. Iwasaka, and S. Fukuhara Activated Platelet and Oxidized LDL Induce Endothelial Membrane Vesiculation: Clinical Significance of Endothelial Cell-Derived Microparticles in Patients With Type 2 Diabetes Clinical and Applied Thrombosis/Hemostasis, July 1, 2004; 10(3): 205 - 215. [Abstract] [PDF]

				Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2004; 27(90001): s47 - 47. [Full Text] [PDF]

				The Diabetes Control and Complications Trial/Epide Intensive Diabetes Therapy and Carotid Intima-Media Thickness in Type 1 Diabetes Mellitus N. Engl. J. Med., June 5, 2003; 348(23): 2294 - 2303. [Abstract] [Full Text] [PDF]

				T. J. Orchard, J. C. Olson, J. R. Erbey, K. Williams, K. Y.-Z. Forrest, L. Smithline Kinder, D. Ellis, and D. J. Becker Insulin Resistance-Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care, May 1, 2003; 26(5): 1374 - 1379. [Abstract] [Full Text] [PDF]

				P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men Arterioscler. Thromb. Vasc. Biol., February 14, 2003; 23(2): 314 - 321. [Abstract] [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2003; 26(90001): s62 - 69. [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Clin. Diabetes, July 1, 2002; 20(3): 109 - 116. [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Spectr, July 1, 2002; 15(3): 147 - 157. [Full Text] [PDF]

				L. S. Hermann and N. Wiernsperger Impaired glucose tolerance and metformin: clinical and mechanistic aspects The British Journal of Diabetes & Vascular Disease, May 1, 2002; 2(3): 177 - 183. [Abstract] [PDF]

				American Diabetes Association The Prevention or Delay of Type 2 Diabetes Diabetes Care, April 1, 2002; 25(4): 742 - 749. [Full Text] [PDF]

				E. B. Jude, S. O. Oyibo, N. Chalmers, and A. J.M. Boulton Peripheral Arterial Disease in Diabetic and Nondiabetic Patients: A comparison of severity and outcome Diabetes Care, August 1, 2001; 24(8): 1433 - 1437. [Abstract] [Full Text] [PDF]

				M. A. Crook, J. C. Pickup, P. J. Lumb, F. Georgino, D. J. Webb, and J. H. Fuller Relationship Between Plasma Sialic Acid Concentration and Microvascular and Macrovascular Complications in Type 1 Diabetes: The EURODIAB Complications Study Diabetes Care, February 1, 2001; 24(2): 316 - 322. [Abstract] [Full Text]

				Y. M. Agazie, J. C. Bagot, E. Trickey, S. P. Halenda, and P. A. Wilden Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H795 - H801. [Abstract] [Full Text] [PDF]

				M. Carlsson, Y. Wessman, P. Almgren, and L. Groop High Levels of Nonesterified Fatty Acids Are Associated With Increased Familial Risk of Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1588 - 1594. [Abstract] [Full Text] [PDF]

				M Bouma, J. Dekker, J. van Eijk, F. Schellevis, D. Kriegsman, and R. Heine Metabolic control and morbidity of Type 2 diabetic patients in a general practice network Fam. Pract., August 1, 1999; 16(4): 402 - 406. [Abstract] [Full Text] [PDF]

				S. D. Kanters, J.-D. Banga, R. P Stolk, and A. Algra Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis Vascular Medicine, May 1, 1999; 4(2): 67 - 75. [Abstract] [PDF]

				J. C. Will, K. F. Strauss, J. M. Mendlein, C. Ballew, L. L. White, and D. G. Peter Diabetes Mellitus among Navajo Indians: Findings from the Navajo Health and Nutrition Survey J. Nutr., October 1, 1997; 127(10): 2106 - 2106. [Abstract] [Full Text]

				L. E. Wagenknecht, R. D'Agostino Jr, P. J. Savage, D. H. O'Leary, M. F. Saad, and S. M. Haffner Duration of Diabetes and Carotid Wall Thickness : The Insulin Resistance Atherosclerosis Study (IRAS) Stroke, May 1, 1997; 28(5): 999 - 1005. [Abstract] [Full Text]

				C. E. Lloyd, L. H. Kuller, D. Ellis, D. J. Becker, R. R. Wing, and T. J. Orchard Coronary Artery Disease in IDDM : Gender Differences in Risk Factors but Not Risk Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 720 - 726. [Abstract] [Full Text]

				R. D. Lasker The Diabetes Control and Complications Trial -- Implications for Policy and Practice N. Engl. J. Med., September 30, 1993; 329(14): 1035 - 1036. [Full Text]